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Abstract 
 
Clinicians have always been aware of the importance of using clinical tests and 
measures that are valid and reliable – and avoiding those that are not. However, the 
choice of which tests and measures to use is often more a matter of personal 
preference, arising out of knowledge of the test‟s psychometric properties and one‟s 
experience with the test, rather than on a systematic critical appraisal of assessment 
tools. This paper outlines a proposal for how clinical assessments in the speech and 
language sciences can be critically appraised for the purpose of deciding whether they 
are likely to be informative in diagnosing individuals with communication disorders. 
QUADAS, a 14-item evidence-based critical appraisal tool (Whiting et al., 2003), 
originally designed to assess the quality of diagnostic accuracy studies used in 
systematic reviews in medicine, is presented with an example of how it can be applied 
in the field of communication disorders. 
 
Keywords: evidence-based practice, diagnostic accuracy, critical appraisal, 
assessment 
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Considerations for Appraising Diagnostic Studies of Communication Disorders 
 
Accurate assessment of individuals with communication disorders provides 
the foundation for clinicians‟ decisions about diagnosis and intervention. Without 
accurate assessment, decisions about whether to offer intervention, what type to offer, 
and whether it was effective, are not possible. This paper is concerned with the 
question of how clinicians
1
 can go about the challenging task of evaluating the 
usefulness of specific clinical assessment tools (e.g., standardized tests, language 
sample measures, instrumental measurements) designed to diagnose individuals with 
communication disorders, using a framework grounded in evidence-based practice 
(EBP). The focus here is on assessments intended for diagnosis (or classification) by  
“detecting or excluding disorders, by increasing diagnostic certainty as to their 
presence or absence” (Knottnerus & van Weel, 2002, p. 3) rather than on assessments 
designed for other purposes, such as measuring treatment progress, assessing 
prognosis or tracking the clinical course of a disorder for clients already diagnosed. 
The paper is presented from the perspective of the clinician faced with the task of 
assessing individuals suspected of having communication disorders, rather than from 
the perspective of those developing tests and measures, and draws on ideas presented 
previously by Klee, Wong, Stokes, Fletcher and Leonard (in press). 
 In that paper, we argued that evidence-based assessment is the joint product of 
those who develop clinical assessment measures and those who use them. Although 
the current paper focuses on the latter, and in particular on how clinicians can decide 
whether a particular test or measure is likely to be useful to them in their daily 
practice, many of the concepts are equally relevant to test developers. The focus is on 
evaluating current tests and measures rather than on a hypothetical set of ideal 
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measures that may be developed at some point in the future. This is not to suggest that 
developing new methods and models of clinical assessment is unnecessary; it plainly 
is. Rather, this paper outlines a proposal for how to critically appraise new clinical 
tests and measures appearing in the literature or ones that are already in use. Like all 
proposals, it is one that should be debated. The proposal is based on a model 
originating in evidence-based medicine and one that is specifically concerned with 
how to evaluate the diagnostic accuracy of tests and measures. This will be introduced 
later in the paper. Following that, we present an evidence-based tool that can be used 
by clinicians to assess the quality of diagnostic accuracy studies. First, we briefly 
review the standard psychometric assessment model that has been used to develop 
new assessment measures in the fields of psychology, education and speech and 
language sciences. 
 
Psychometric Assessment of Tests and Measures 
Traditionally, when a new test or measure is developed, data are collected 
from a research sample or from a representative sample of individuals selected from 
the population; the latter is usually referred to as a normative group. In the clinical 
setting, a client‟s performance on the test or measure is then compared to the range of 
scores produced by the normative group, usually by converting the raw score (e.g., a 
test score or a language sample measure such as mean length of utterance or percent 
consonants correct) to one of several standardized scores (e.g., percentile, z-score, 
standard score, or in the case of a child, an age-equivalent score). Those whose 
standardized score falls below a certain criterion (e.g., 1.5 standard deviations [SD] 
below the group mean or z = -1.50) on a test that has been shown to be 
psychometrically sound may then be considered for clinical services. This paradigm is 
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also typically used in research studies to operationally define individuals from a 
particular clinical population. For instance, children with specific language 
impairment (SLI)
 2
 may be selected for an experimental group on the basis of one or 
more standardized language scores falling below a pre-defined level, such as 1.5 SDs 
below the mean (after ruling out certain other conditions such as hearing loss, 
cognitive impairment, and social and emotional problems), whereas those in the 
control group may be selected on the basis of their scores not falling below that level.  
 The framework for assessing the psychometric adequacy of many of the 
clinical tests and measures used in the US and elsewhere in the speech and language 
sciences, psychology and education is presented in the Standards for Educational and 
Psychological Testing  (American Educational Research Association, American 
Psychological Association & National Council on Measurement in Education,  
1999). It describes in detail technical standards for test construction and evaluation, 
including various aspects of test validity and reliability, the contents of the technical 
and user‟s manuals, and guidelines relating to professional standards of test use. 
Using these, McCauley and Swisher (1984) formulated a review of 30 developmental 
speech and language tests in use at the time, based on a set of 10 key psychometric 
criteria relating to the adequacy of the normative sample, the presentation of test 
procedures and norms, test validity and test reliability. They concluded from their 
review that half of the tests met no more than two criteria while only three tests met 
more than four criteria. 
A decade later, Plante and Vance (1994) updated McCauley and Swisher‟s 
review in their examination of 21 preschool language tests, employing the same set of 
psychometric criteria as were used previously. Then, in what was a ground-breaking 
departure from the traditional psychometric assessment paradigm in use at the time, 
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they examined how accurate four of the tests were in differentiating children with and 
without SLI. They reported the sensitivity and specificity of each test based on cut-off 
scores that had been empirically determined, rather than relying on an arbitrary cut-off 
score (e.g., z = -1.50). Children in the SLI group were recruited from clinics and 
schools serving those children while children without SLI came from a local 
preschool. The cut-off z-score that most accurately discriminated the groups varied 
between +0.06 to -3.35 across the tests. They concluded that only one of the tests 
demonstrated an acceptable level of classification accuracy, in that it correctly 
identified 90% of the children in each group relative to a clinical diagnosis based on 
standardized test performance and clinical judgment. Subsequently, further studies 
examining the diagnostic accuracy of other norm-referenced language tests have come 
to be published (Gray, Plant, Vance, & Henrichsen, 1999; Merrell & Plante, 1997; 
Oetting, Cleveland & Cope, 2008; Perona, Plante, & Vance, 2005; Plante & Vance, 
1995). For a recent review of 43 commercially available tests of child language, see 
Spaulding, Plante and Farinella (2006). In reporting test sensitivity and specificity, 
these were some of the first assessment studies in the field of child language disorders 
that moved beyond the standard psychometric assessment paradigm. The concern for 
diagnostic accuracy of assessment measures was also recognized by Dollaghan and 
Campbell (1998), who reported likelihood ratios for a new nonword repetition task 
designed for use with children. Measures of diagnostic accuracy (e.g., sensitivity, 
specificity, likelihood ratios) have been in use since the 1980s in studies of screening 
instruments designed to identify children with speech and language delay and two 
systematic reviews of these instruments have been published (Law, Boyle, Harris, 
Harkness, & Nye, 2000; Nelson, Nygren, Walker, & Panoscha, 2006). The 
conclusions of both of these systematic reviews were drawn from a sub-set of 
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screening studies that had been selected on the basis of methodological quality. 
Schlosser, Wendt and Sigafoos (2007) discuss ways in which studies can be filtered 
for inclusion in systematic reviews, as well as how various sources of bias can be 
reduced in constructing systematic reviews. 
 
An Evidence-Based Framework for Assessing Diagnostic Accuracy 
 Haynes, Sackett, Guyatt and Tugwell (2006) identified what they called a 
diagnostic quartet of design features that should be incorporated into studies 
evaluating diagnostic tests and measures. For them, “A valid diagnostic study (1) 
assembles an appropriate spectrum of patients; (2) applies both the diagnostic test and 
reference standard to all of them; (3) interprets each blind to the other; and (4) repeats 
itself in a second, independent („test‟) set of patients” (p. 275). They go on to present 
the methods and outcome measures used in such studies and discuss design flaws that 
conspire to make the results of diagnostic accuracy studies less than convincing to 
readers. See Chapter 8 of the third edition of their book (Haynes et al., 2006) and 
Chapter 4 of the second edition (Sackett, Haynes, Guyatt, & Tugwell, 1991) for a full 
discussion of the issues and the quantitative methods involved. The quartet of study 
design features, although it was developed with medical tests in mind, can be applied 
to diagnostic studies in speech and language sciences. These provide the basis for the 
approach taken in this paper. We now briefly describe how each of these features is 
relevant to diagnostic research involving communication disorders, with examples 
from assessment of child language disorders.  
 The first feature requires that for a test or measure to be useful clinically, it 
should be examined with an appropriate spectrum of clients. Most investigations 
designed to evaluate the potential of either clinical measures (e.g., standardized tests 
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or  language sample measures) or experimental procedures (e.g., language processing 
tasks) are conducted by recruiting a group of children who are known to have a 
particular disorder (e.g., SLI) and then comparing them to a group of children known 
to be free of the disorder. For example, children selected as possible candidates for an 
SLI group are almost always recruited from a clinical population by asking clinicians 
to refer children from their caseloads who meet certain criteria. Typically, the children 
in these studies have already been assessed, diagnosed, and sometimes even treated.  
Similarly, children are selected for the control group by recruiting from the general, 
non-clinical, population of typically-developing children. After this initial screening 
process, potential candidates for each group are then usually, but not always, tested 
and selected by virtue of their standardized test scores falling above (for the control 
group) or below (for the SLI group) a pre-determined cut-off level. While Haynes et 
al. (2006) suggest that this “may be appropriate while initially exploring the potential 
of a diagnostic test, [it is] almost certain to be misleading if you are trying to establish 
test properties for use in clinical practice” (p. 290). So ultimately, if a measure is to 
have real-world clinical value in diagnosing SLI, for example, it should be evaluated 
using an appropriate spectrum of children who are representative of what might be 
encountered in a clinical setting, such as individuals who are referred for speech and 
language evaluation by parents, teachers and doctors. Ultimately is used here in its 
literal sense, to mean that a series of studies can be designed in such a way that the 
first principle of the diagnostic quartet occurs during the final phase of evaluating a 
measure‟s diagnostic accuracy. A hierarchy of research investigations for how this 
can be achieved is outlined in the next section of the paper (see Four Phases of 
Diagnostic Research). 
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 The second feature of the diagnostic quartet requires that the test or measure 
(referred to as the index test) and the reference standard are applied to all clients 
recruited to the study. In reviewing the literature on child language disorders, it 
appears that this condition is usually met. Occasionally however, studies of diagnostic 
accuracy have been reported in which only children in the affected group (e.g., SLI) 
received the reference standard while those in the control group (e.g., typically-
developing children) did not. Presumably, those in the control group are assumed to 
be developing normally on the basis of parent or teacher report. The problem here is 
that unless the reference standard is applied to every individual in the control group as 
well, one cannot be certain that they are free of the condition.  
 A further aspect of the second feature concerns the nature of the reference 
standard used to define the condition (e.g., SLI). As has been argued elsewhere, there 
is at present no universally-agreed gold standard for defining SLI (Leonard, 1987; 
Mervis & Robinson, 2005; Tager-Flusberg, 2005). However, Tomblin, Records and 
which Zhang (1996) have proposed an empirically-determined measure, the epiSLI 
standard, could be considered a candidate. This is not unlike the situation with respect 
to a number of medical and psychiatric conditions. In the absence of a gold standard, a 
reference standard can be defined. One approach to this has been to define a cut-off 
score on a test which is used in conjunction with a set of relevant exclusionary 
criteria. Although this has the advantage of being replicable, the diagnostic accuracy 
of the reference test itself may not be known.  
 The third feature requires that the index test and the reference standard are 
each interpreted blind to the other. If the diagnostic status of the child is known to the 
examiner at the time the index test is administered or scored, then the third feature of 
the diagnostic quartet is compromised. To avoid this, steps must be taken to blind the 
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examiner as to the diagnostic status of the child at the time the testing or language 
sample takes place, since a priori knowledge of the child‟s diagnostic status may 
inadvertently bias the way in which the test is administered or the way the language 
sample is taken, particularly if the interlocutor during the language sample is the 
examiner. Steps must also be taken to blind any data coders down the line with 
respect to the diagnostic status of the child. For example, if a transcriber is overtly 
aware of the diagnostic status of the child (or the age or sex of the child, if the 
measure varies as a function of these) at the time the language sample is transcribed 
and analyzed, this could bias the results in various ways. If the data coder is aware 
that the child they are listening to, transcribing, or coding is language disordered – 
and also aware, for example, that such children are likely to omit certain 
morphological markers in their speech with greater frequency than typically-
developing children – that has the potential for biasing the way they „hear‟, transcribe, 
or code the presence or absence of such morphemes. Although having a second 
transcriber independently re-transcribe some of the data for reliability purposes offers 
a degree of control, the potential for bias is still there. The only way to minimize bias 
in this situation is to completely blind the examiner and any data coders with respect 
to the diagnostic status, age and sex of the child. Authors of diagnostic accuracy 
studies need to exert the same level of control for bias that authors of randomized 
controlled trials (RCT) strive for. 
 The fourth feature requires that the investigation is repeated on a second, 
independent set of clients. This is discussed in the next section, which presents a 
hierarchy for doing systematic diagnostic research.  
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Four Phases of Diagnostic Research 
Sackett and Haynes (2002a, b) proposed that diagnostic research might take 
place in a series of four phases, with each phase designed to answer a specific 
question. These are outlined below, along with suggestions for how they might be 
applied to diagnostic studies of communication disorders. As before, while the 
examples are drawn from child language disorders, the questions can be applied to 
any clinical population. 
Phase I question: Do clients with the target disorder have different test results 
from normal individuals? This question is asked during the initial stage of the 
research, where the investigator is trying to find out whether a new measure or 
procedure has the potential for distinguishing affected from unaffected individuals. In 
this phase, it is reasonable to recruit children from a known clinical population (e.g., 
children with SLI who are on a waiting list to receive intervention) and compare them 
to children from a non-clinical population (e.g., children in a preschool or nursery 
who are developing language normally). The developmental status of each child 
would then be confirmed by administering the components making up the reference 
standard (e.g., standardized language test, audiological screening, and any other 
measure thought to be relevant to the disorder of interest). The standardized test or 
experimental measure being investigated (referred to as the index test) would then be 
administered and an appropriate statistical procedure (e.g., a test of mean differences) 
would be used to determine whether the two groups differed in their performance on 
the index test. Many studies of the diagnostic accuracy of tests and measures in child 
language have only ever been evaluated as a phase I question (e.g., Klee, 1992), with 
the research never progressing to the next phase. An advantage of performing a phase 
I study is that it is “quick and relatively cheap to carry out, and a negative result saves 
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having to proceed to the tougher, more time consuming, and costlier questions of 
phases II-IV” (Sackett and Haynes, 2002b, p. 539). 
Phase II question: Are clients with certain test results more likely to have the 
target disorder than clients with other test results? If the answer to the phase I 
question was yes, the research can proceed to phase II. In this phase, the goal is to 
establish whether clients with certain results on the index test are more likely to have 
the disorder than clients below, or above, that level. Sackett and Haynes (2002a, b) 
indicate that at times the dataset that was used in phase I can also be used in phase II, 
but that the goal in the second phase is to find the cut-off score that differentiates 
affected from unaffected individuals with the highest level of accuracy. It is beyond 
the scope of this paper to review the methods and measures by which this is done, but 
interested readers are directed to Chapter 4 of Sackett et al. (1991) and Chapter 8 of 
Haynes et al. (2006). For convenience however, a list of the main outcome measures, 
along with definitions, is provided in Table 1. 
-- Insert Table 1 about here. -- 
Phase III question: Does the test distinguish clients with and without the 
target disorder among clients in whom it is clinically reasonable to suspect that the 
disorder is present? The next phase of the research evaluates whether the test or 
measure is capable of differentiating those with and without the target disorder in a 
clinical sample. Previously, phase I will have established that the index test produced 
different results, on average, in groups with and without the disorder, while phase II 
will have established the optimal cut-off level for the test. At phase III, the index test 
would be trialled on a sample of clients who have been referred because of concerns 
raised by parents, teachers, doctors or others. In the case of an index test for SLI, for 
example, the referred sample might contain children with a wide range of conditions 
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associated with speech and language difficulties, including conditions such as 
cognitive impairment, hearing impairment, and autism spectrum disorders. In the case 
of an instrument designed to screen children for language delay, the target sample 
might be either a particular group of individuals known to be at high-risk of having 
the condition or a group of unselected individuals in the general population who are 
pre-symptomatic at the time of screening (e.g., Klee, Carson, Gavin, Hall, Kent & 
Reece, 1998; Laing, Law, Levin & Logan, 2002; Stokes, 1997). Thus, the “correct” 
target group may differ depending on the intended purpose of the index test. 
Phase IV question: Do clients who undergo the diagnostic test fare better (in 
their ultimate health outcomes) than similar clients who are not tested?  The last 
phase of evaluating an index test poses the difficult question of whether individuals 
who receive the index test have better (speech, language, or functional) outcomes than 
those who were not given the test. This question has long been recognized as being 
part of the process by which screening measures are evaluated (e.g., Cochrane & 
Holland, 1971; Wilson & Jungner, 1968), but has rarely been asked of assessments in 
speech and language sciences. This phase of the research will usually require an RCT. 
Law et al. (2000) presented a model for how this might be done in screening studies 
and de Koning et al. (2004) conducted a study attempting to do just that.  
 
Critical Appraisal of Studies of Diagnostic Accuracy 
In the opening pages of her very readable introduction to evidence-based 
medicine, Trisha Greenhalgh summarizes five key steps originally proposed by David 
Sackett and colleagues (e.g., Sackett & Rosenberg, 1995) with regard to developing 
an evidence-based practice. These are (1) “to convert our information needs into 
answerable questions (i.e., to formulate the problem); (2) to track down, with 
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maximum efficiency, the best evidence with which to answer those questions…; (3) to 
appraise the evidence critically (i.e., weigh it up) to assess its validity (closeness to the 
truth) and usefulness (clinical applicability); (4) to implement the results of this 
appraisal in our clinical practice; and (5) to evaluate our performance.” (Greenhalgh, 
2006, p. 2; see also Straus, 2007). From here, the current paper focuses on the third of 
these – critically appraising the evidence regarding tests and measures used to assess 
and diagnose individuals with communication disorders. Critical appraisal involves an 
assessment of methodological quality (Greenhalgh, 2006); it provides a means for 
judging the quality of the evidence that will be brought to bear on deciding which 
clinical assessment tools are worthwhile and which are not. 
Several critical appraisal checklists have been developed for evaluating the 
methodological quality of studies of diagnostic tests and measures. A selection of 
these follows: 
 The website of the Scottish Intercollegiate Guidelines Network 
(http://www.sign.ac.uk) contains six critical appraisal checklists, with notes on 
how to use them, for evaluating various types of studies, including systematic 
reviews and meta-analyses, RCTs, cohort studies, case-control studies, 
diagnostic studies, and economic evaluations. The checklist for diagnostic 
studies (Scottish Intercollegiate Guidelines Network, 2004) contains 22 items, 
including questions relating to internal validity (i.e., methodological quality) 
and study details, such as sample size and measures of diagnostic accuracy 
(e.g., sensitivity, specificity, positive predictive value [PPV], negative 
predictive value [NPV], and likelihood ratios [LR]). 
 The website of the Centre for Evidence-Based Medicine at Oxford University 
(http://www.cebm.net) contains critical appraisal worksheets for systematic 
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reviews, RCTs, and diagnostic studies. Items on the worksheets are 
accompanied by notes and calculations to help the user answer the question. 
 Greenhalgh (2006) provides an appendix containing checklists for finding, 
appraising and incorporating evidence into clinical practice. Included in this is 
a 10-item checklist with questions specifically related to papers about 
diagnostic or screening tests.   
 CADE (Critical Appraisal of Diagnostic Evidence; Dollaghan, 2007) is a 13-
point checklist for evaluating the methodological quality of diagnostic 
accuracy studies, including an evaluation of the strength and precision of two 
study outcome measures (see also Dollaghan, 2004). One particularly useful 
feature of this checklist is that reviewers are asked to formulate the explicit 
diagnostic question, called a Foreground Question, which was addressed by 
the study under review. An example of such a question is, “For identifying 
preschoolers in need of further evaluation, what is the accuracy of the new 
screening test as compared with the results of a diagnostic evaluation?” 
(Dollaghan, 2007, p. 103). 
 QUADAS (Quality Assessment of Diagnostic Accuracy Studies; Whiting et 
al., 2003) is a 14-point checklist that will be discussed further below. 
While these checklists have a lot in common with one another, they differ with 
respect to their breadth of coverage and length. Consequently, clinicians and 
reviewers may come to different conclusions about the quality of a diagnostic study 
partly as a consequence of using different checklists. This brings us back to a point 
made earlier, that evidence-based assessment is the joint product of those who 
develop assessment measures and those who use them. Despite the availability of a 
number of different critical appraisal checklists, at times it is difficult to judge the 
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quality of evidence in published studies because of the way in which they have been 
reported. Evidence-based assessment can be facilitated if authors aim for complete 
and accurate reporting of key features in their papers and if clinicians have a means of 
critically appraising those studies in a consistent and comprehensive way.  
Two evidence-based checklists have recently been developed for reporting and 
critically appraising diagnostic tests and measures. One is aimed at test developers 
and the other at test users. The STARD checklist (Standards for Reporting of 
Diagnostic Accuracy) and accompanying flow chart were designed “to improve the 
accuracy and completeness of reporting of studies of diagnostic accuracy” (Bossuyt et 
al., 2003a, p. 41). To date over 50 journals, including the journals of the American 
Speech-Language-Hearing Association, require authors of diagnostic studies to use 
STARD when preparing manuscripts for submission to those journals. The STARD 
checklist contains 25 items covering key points within the title, abstract, and 
keywords of the article and the introduction, methods, results, and discussion sections. 
Authors are also encouraged to provide a flow chart that tracks the sequence and 
progression of participants through the study. Further information regarding each item 
on the checklist may be found in a companion paper (Bossuyt et al., 2003b) and on 
the STARD website (http://www.stard-statement.org). While STARD was developed 
for authors of diagnostic accuracy studies, it was not intended to be used by readers as 
a critical appraisal checklist (http://www.stard-statement.org/website%20stard/, 
accessed December 3, 2007). 
The QUADAS tool (Whiting et al., 2003) was designed for appraising the 
methodological quality of diagnostic tests and measures. This checklist was developed 
for assessing studies of diagnostic accuracy included in systematic reviews, but it can 
also be used by clinicians for assessing the methodological quality of individual 
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studies. For example, QUADAS was used recently to critically appraise a screening 
study in this journal (Klee, 2007). The QUADAS tool is itself evidence-based, in that 
its face validity was assessed using a formal consensus method (a Delphi procedure) 
by a panel of experts after conducting reviews of the diagnostic literature to locate 
potential items. It was then put through field trials to assess its consistency, construct 
validity, and usability. A recent empirical evaluation of QUADAS found that the 
interrater agreement across checklist items was very good (Whiting, Weswood, 
Rutjes, Reitsma, Bossuyt, & Kleijnen, 2006). The tool contains 14 items and is 
reproduced in Table 2. 
-- Insert Table 2 about here. -- 
 
Critical Appraisal using QUADAS: an example 
The remainder of this paper will illustrate the use of QUADAS in critically 
appraising a screening study. The decision to use QUADAS was taken on the basis of 
the extensive field work that has been undertaken in developing this tool (Whiting, 
2006) as well as on the decision to separate methodological quality from study 
outcomes. Although QUADAS focuses on the former, users may decide to then 
examine the study‟s outcomes provided the methodological quality of the study is 
sufficiently high. As in any research study, a study‟s results are undermined if 
methodological quality is not first demonstrated. 
To illustrate its use, a screening study is critically appraised (Klee, Pearce, & 
Carson, 2000). This study involved a further analysis of data originally presented in 
Klee et al. (1998). In the earlier study, the Language Development Survey (LDS; 
Rescorla, 1998) was mailed to parents at the time of their child‟s second birthday. The 
LDS was designed as a screening questionnaire to detect the presence of early 
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language delay in children. It contains a vocabulary checklist and a question about 
whether the child has begun to combine words. It also contains questions about the 
child‟s sex, birth order, prematurity, number of ear infections, and family history of 
late talking, among other things. Parents were also asked whether they had any 
concerns about their child‟s language, communication or hearing abilities. A total of 
306 parents completed the questionnaire. Follow-up clinical evaluations were then 
offered to the parents of all children who screened positive on the LDS (n = 45), as 
defined by Rescorla‟s Delay 3 criterion (<50 words or no word combinations), and a 
random sample of those who screened negative. The parents of 64 children (17 screen 
positives; 47 screen negatives) agreed to participate in the follow-up evaluation.  
The 2000 study had two goals, but for the purpose of this review, only the first 
is critically appraised. The first goal of that study was “to explore whether the positive 
predictive value of the screening program we reported earlier (Klee et al., 1998) could 
be increased while maintaining the high sensitivity, specificity, and NPV of the 
original screening criterion. We attempted to refine the pass-fail criterion we 
originally used (viz., Rescorla‟s [1989] Delay 3 criterion) by taking into account other 
information provided by parents on the screening questionnaire” (p. 824). 
It is worth mentioning that neither STARD nor QUADAS were available to 
the authors at the time the study was conducted and written up. The study is evaluated 
below by answering Yes, No, or Unclear to each of the 14 QUADAS items, following 
the definitions of each given in Whiting et al. (2003). Each decision is accompanied 
by supporting evidence which takes the form of a passage and page number from 
either the 1998 or 2000 paper. For some items, responses are supplemented by a 
reviewer comment, although this is not strictly part of the tool‟s protocol. 
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1. Was the spectrum of patients representative of the patients who will receive the 
test in practice? No: “Screening questionnaires...were mailed to 650 families over 
a period of 25 consecutive months; 582 were successfully delivered, and 306 
(53%) were completed and returned by parents” (2000, p. 824). Reviewer 
comment: The spectrum in a screening study is considered to be the population. 
The spectrum in this study is represented by a biased sample, in that nearly half of 
the available population did not participate in the screen (screening yield = 53%). 
While “no information was available regarding those parents who did not return 
the [screening] survey”, several explanations were provided (1998, p. 630). 
2. Were selection criteria clearly described? Yes. “Most children were initially 
identified from birth announcements in local newspapers. These were then cross-
referenced with the local telephone directory to provide current addresses. In 
addition, postcards were distributed to parents of 18-to 24-month-old children 
through local physicians‟ offices, County Public Health offices, the Women Infant 
and Children (WIC) Program office, and 28 home- and center-based day care 
facilities. The postcards notified parents of a free speech and language screening 
and indicated that they could return the postcard if they were interested in having 
their child screened when the child turned 2. Names, addresses, and birthdates 
from both these sources were entered into a computer database that was used to 
generate a list of children to be screened each month” (1998, p. 629). 
3. Is the reference standard likely to correctly classify the target condition? Yes. 
“Following the clinical evaluation, each child‟s overall language status was 
categorized as either normal (LN) or delayed (LD). Categorization was based on 
the clinical judgement of two independent examiners after reviewing all the data 
collected during the clinical evaluation. For children categorized as LD, clinical 
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concern had to be registered by each of the examiners. In addition, the child‟s 
performance on at least one of three standardized language measures had to fall 
one standard deviation (SD) or more below the population mean. These included 
the LRO (Language Receptive Organization; italics added by this author) and 
LEO (Language Expressive Organization) scales of the MSEL (Mullen Scales of 
Early Learning) and mean length of utterance in morphemes.... The LD group 
consisted of children for whom intervention was recommended...as well as those 
for whom re-evaluation was recommended in order to monitor development.... For 
children categorized as LN, no clinical concern was expressed by either examiner, 
and all three standardized language measures were within normal range (LRO, 
LEO, and MLU all above -1 SD from the mean” (2000, p. 824). Reviewer 
comment: The target condition was in this case defined as language delay rather 
than language disorder. The reference standard used in this study is in line with 
other studies of late talkers and is appropriate given that there is no commonly 
agreed upon gold standard for what constitutes a developmental language disorder 
in toddlers who are otherwise developing normally. 
4. Is the time period between reference standard and index test short enough to be 
reasonably sure that the target condition did not change between the two tests? 
Yes. “A double-blind clinical evaluation was conducted on a sample of the 
children 1 month after screening...” (2000, p. 824). Reviewer Comment: Since 
the natural history of the target condition is not known at this time, it is possible 
that some of the children changed in the interval between screening and follow-up 
(e.g., vocabulary spurt).  
5. Did the whole sample or a random selection of the sample, receive verification 
using a reference standard of diagnosis? No. “We attempted to evaluate all the 
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children who screened positive (17 of 45) and a random sample of those who 
screened negative (47 of 261)” (2000, p. 824). Reviewer comment: Of those who 
screened positive, only 38% were given follow-up evaluations: “...some could not 
be assessed further because of scheduling conflicts and illnesses or because 
parents either could not be contacted or were unwilling to participate” (1998, pp. 
630-1). 
6. Did patients receive the same reference standard regardless of the index test 
result? Yes. “The clinical evaluation included a parent interview, standardized 
audiological and development testing (Mullen Scales of Early Learning, MSEL; 
Mullen, 1993; originally published in Infant and Preschool versions), direct 
observation of the child with both familiar (parent) and unfamiliar individuals 
(examiner), and a quantitative analysis of a sample of conversational language 
during play” (2000, p. 824).  
7. Was the reference standard independent of the index test (i.e. the index test did not 
form part of the reference standard)? Yes. The index test (LDS) did not form part 
of the reference standard; see the evidence presented for item 6. 
8. Was the execution of the index test described in sufficient detail to permit 
replication of the test? Yes. “To screen positive, the child had to meet the Delay 3 
criterion and the parent either had to indicate concern for the child‟s language 
development or report that the child had experienced six or more ear infections 
during the first 2 years of life. This combination of factors [was] referred to as the 
Delay 3+ criterion...” (2000, p. 826). Reviewer comment: The original Delay 3 
criterion was defined as less than 50 words of expressive vocabulary or no 
evidence of word combinations on the LDS (Rescorla, 1989). 
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9. Was the execution of the reference standard described in sufficient detail to permit 
its replication? Yes. Refer to the evidence provided for items 3 and 6. 
10. Were the index test results interpreted without knowledge of the results of the 
reference standard? Yes. “A double-blind clinical evaluation was conducted...1 
month after screening...” (2000, p. 824). 
11. Were the reference standard results interpreted without knowledge of the results 
of the index test? Yes. “At the time of testing, both the examiners and the child‟s 
parent(s) were blind with respect to the screening outcome” (1998, p. 631).  
12. Were the same clinical data available when test results were interpreted as would 
be available when the test is used in practice? Not relevant. Reviewer comment: 
The instructions for QUADAS allow for this item to be omitted in cases where 
“the interpretation of the index test is fully automated and involves no 
interpretation” (Whiting et al., 2003). Deciding whether the screening outcome 
was positive or negative is straightforward in the case of the LDS. 
13. Were uninterpretable/intermediate test results reported? Yes. Reviewer 
comment: No uninterpretable or intermediate test results were reported. A 
proposed modification to the QUADAS background document indicates that “If it 
is clear that all test results...are reported, then this item would be scored as „yes‟ ” 
(Whiting et al., 2006, Table 4). 
14. Were withdrawals from the study explained? Yes. Reviewer comment: Table 4 of 
Whiting et al. (2006) also indicates that “If is clear what happened to all patients 
who entered the study... then this item would be scored as „yes‟ ”. 
Having completed critically appraising this paper using QUADAS and 
deciding that the methodological quality was sufficiently high to warrant examining 
the study outcomes, a comment will be made about these. While this study 
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demonstrated that the revised Delay 3+ criterion resulted in improved point estimates 
of diagnostic accuracy (specificity, PPV, LRs) relative to the original Delay 3 
criterion, these were accompanied by large confidence intervals, probably due to the 
small size of the clinical follow-up sample (see Table 1). Although the screening 
results look promising on the basis of the evidence presented, it is far from clear 
whether they would hold up in a population screening program. This led the authors to 
warn that “Further investigation involving a larger sample…would allow us to place 
more confidence in the screening model proposed here” (Klee et al., 2000, p. 831). 
Notice that the assessment of methodological quality was done without any 
reference to the results of the study (which are presented in Table 1). Herein lies 
another benefit of using QUADAS over some of the other critical appraisal checklists. 
Unless the methods used in the research are sound to begin with, the results cannot be 
trusted. Whether the results can be trusted in the case of the study reviewed here will 
be left up to the reader to decide. A caveat is worth mentioning here. It is possible that 
since the reviewer also happened to be one of the authors of the paper being reviewed, 
the review itself is biased. Interested readers are therefore encouraged to do their own 
review of this study, using QUADAS and the item definitions in Whiting et al. 
(2006), and compare their evaluation to the one above. Of course, investigators are 
not likely to critically appraise their own studies in the post-hoc fashion done here, 
although this has been a worthwhile exercise in self-reflection for this investigator! 
Use of the STARD checklist by investigators of diagnostic accuracy studies, coupled 
with rigorous research design, will help ensure that readers can properly evaluate their 
work when it comes time to using QUADAS for critical appraisal.  
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Summary and Conclusions 
As we wrote in an earlier paper (Klee et al., in press), the deputy editor of the 
BMJ suggested that “while evidence based treatment is well on the way to being 
sorted out, evidence based diagnosis is still in the dark ages” (Delamothe, 2006). 
Although he was referring to diagnosis in medicine, the same could be said of 
diagnosis in speech-language pathology. Much stands to be gained if authors of tests 
and measures used to diagnose communication disorders design their investigations so 
that their diagnostic accuracy can be determined. Further, authors can improve the 
way in which they communicate the details of their investigations to readers if they 
follow the STARD guidelines. Finally, clinicians and reviewers can critically appraise 
the methodological quality of these studies by using the QUADAS tool. Taken 
together, these three things have the potential for moving the state of the art in speech 
and language assessment closer to the ideal of an evidence-based practice.
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Endnotes 
1 
Throughout the paper, the term clinician will be used since the professionals who 
typically work with individuals having communication difficulties are referred 
differently throughout the world (e.g., Speech-Language Pathologist in the USA, 
Speech and Language Therapist in the UK, Speech Pathologist in Australia, Speech 
Therapist in Hong Kong). Similarly, the terms client and patient will be used 
interchangeably when referring to individuals with speech and language difficulties.  
2 
Although the examples throughout the paper will be from child language disorders, 
the same principles apply to any area of speech-language pathology. 
3 
Calculations were carried out to four decimal places and rounded to two at the last 
stage for the figures reported in Table 1. 
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Table 1 
Performance of the LDS as a screening measure for language delay in 24-month-old 
children, using the revised screening criterion (Klee, Pearce & Carson, 2000). 
 
 Clinical outcome  
Language 
delayed 
Language 
normal 
Totals 
Screening 
outcome (LDS 
Delay 3+) 
Positive 10 2 12 
Negative 1 51 52 
 Totals 11 53 64 
 
Outcome measures (with 95% confidence intervals)
3
 and definitions: 
Sensitivity = 10/11 = .91 (.62 - 1.00); proportion of those with the target condition 
who have a positive test result. 
Specificity = 51/53 = .96 (.87 - . 99); proportion of those without the target condition 
who have a negative test result. 
Positive predictive value (PPV) = 10/12 = .83 (.55 - . 95); proportion of those with a 
positive test result who have the target condition. 
Negative predictive value (NPV) = 51/52 = .98 (.90 - 1.00); proportion of those with a 
negative test result who are free of the target condition. 
Likelihood ratio for a positive test (LR+) = .91/(1.00 - .96) = 24.1 (6.1 - 95.0); the 
number of times a positive screening outcome is likely to occur in those with, as 
opposed to those without, the target condition. 
Likelihood ratio for a negative test (LR-) = (1-.91)/.96 = 0.09 (0.02 - 0.61); the 
number of times a negative screening outcome is likely to occur in those with, as 
opposed to those without, the target condition.
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Table 2. QUADAS checklist for assessing the quality of studies of diagnostic 
accuracy. 
 
Item  Yes No Unclear 
1. Was the spectrum of patients representative of the 
patients who will receive the test in practice? 
(  ) (  ) (  ) 
2. Were selection criteria clearly described? (  ) (  ) (  ) 
3. Is the reference standard likely to correctly classify 
the target condition? 
(  ) (  ) (  ) 
4. Is the time period between reference standard and 
index test short enough to be reasonably sure that 
the target condition did not change between the two 
tests? 
(  ) (  ) (  ) 
5. Did the whole sample or a random selection of the 
sample, receive verification using a reference 
standard of diagnosis? 
(  ) (  ) (  ) 
6. Did patients receive the same reference standard 
regardless of the index test result? 
(  ) (  ) (  ) 
7. Was the reference standard independent of the 
index test (i.e. the index test did not form part of 
the reference standard)? 
(  ) (  ) (  ) 
8. Was the execution of the index test described in 
sufficient detail to permit replication of the test? 
(  ) (  ) (  ) 
9. Was the execution of the reference standard 
described in sufficient detail to permit its 
replication? 
(  ) (  ) (  ) 
10. Were the index test results interpreted without 
knowledge of the results of the reference standard? 
(  ) (  ) (  ) 
11. Were the reference standard results interpreted 
without knowledge of the results of the index test? 
(  ) (  ) (  ) 
12. Were the same clinical data available when test 
results were interpreted as would be available when 
the test is used in practice? 
(  ) (  ) (  ) 
13. Were uninterpretable/intermediate test results 
reported? 
(  ) (  ) (  ) 
14. Were withdrawals from the study explained? (  ) (  ) (  ) 
 
Used with permission. From Whiting et al. (2003). The development of QUADAS: a 
tool for the quality assessment of studies of diagnostic accuracy included in 
systematic reviews. BMC Medical Research Methodology, 3, 25. 
 
 
 
